Abstract:Introduction: Arylboronates afford rapid aqueous F-18-labeling via the creation of a highly polar F-18-aryltrifluoroborate anion (F-18-ArBF3-).Hypothesis: Radiosynthesis of an F-18-ArBF3- can be successfully applied to a clinically relevant peptide. To test this hypothesis we labeled dimeric-cylcoRGD, [c(RGDfK)](2)E because a) it is molecularly complex and provides a challenging substrate to test the application of this technique and b) [c(RGDfK)](2)E has already been labeled via several F-18-labeling methods which provide for a preliminary comparison.Goal: To validate this labeling method in the context of a complex and clinically relevant tracer to show tumor-specific uptake ex vivo with representative PET images in vivo.Methods: An arylborimidine was conjugated to [c(RGDfK)](2)E to give the precursor [c(RGDfK)](2)E-ArB(dan) which was aliquoted and stored at-20 degrees C. Aliquots of 10 or 25 nmol containing only micrograms of precursor were labeled using relatively low levels of F-18-activity. Following purification eight mice (pre-blocked/unblocked) with U87M xenograft tumors were injected with [c(RGDfK)(2)E-F-18-ArBF3- (n = 4) for ex vivo tissue dissection. Two sets of mice (pre-blocked/unblocked) were also imaged with PET-CT (n = 2).Results: The [c(RGDfK)](2)E-ArB(dan) is converted within 15 min to [c(RGDfK)](2)E-F-18-ArBF3- in isolated radiochemical yields of similar to 10% (n = 3) at a minimum effective specific activity of 0.3 Ci/mu mol. Biodistribution shows rapid clearance to the bladder via the kidney resulting in high tumor-to-blood and tumor-to-muscle ratios of >9 and >6 respectively while pre-blocking with [c(RGDfK)](2)E showed high tumor specificity. PET imaging showed good contrast between tumor and non-target tissues confirming the biodistribution data.Conclusion: An arylborimidine-RGD peptide is rapidly F-18-labeled in one step in good yield at useful specific activity. Biodistribution studies with blocking controls show tumor specificity which is corroborated by PET images.Advances in Knowledge and Implications for patient Care: Despite many antecedent examples of labeled RGD tracers this work is the first to show direct aqueous labeling of bisRGD with an F-18-ArBF3-. Labeling occurs in near record rapidity (45 min) at useful effective specific activities and competitive yields for high contrast tumor specific images. As bisRGD has been imaged in humans with several prosthetics this work suggests potential clinical applications of tracers appended with an F-18-ArBF3- More generally the ability to label a molecularly complex tracer suggests that this method could be useful to label many other peptides. Furthermore these results portend the development of kits that use only microgram quantities of lyophilized precursor for on demand labeling. The ability to perform one-step aqueous labeling in under an hour to provide tracers with high T:NT ratios has important implications for developing radiotracers for use in fundamental research and in preclinical tracer studies. (C) 2013 Elsevier Inc. All rights reserved.

Legumain-Triggered Macrocyclization of Radiofluorinated Tracer for Enhanced PET Imaging

Development of a Radiotracer for PET Imaging of the SNAP Tag.

Dual-Targeting PET Tracers Enable Enzyme-Mediated Self-Assembly for the PET Imaging of Legumain Activity

One-step Radiosynthesis of 18F-Alf-nota-rgd2 for Tumor Angiogenesis PET Imaging

Radiosynthesis and Evaluation of 4-(6-[18f]fluoro-4-(5-isopropoxy-1h-indazol-3-yl)pyridin-2-yl)morpholine As a Novel Radiotracer Candidate Targeting Leucine-Rich Repeat Kinase 2.

Towards imaging the immune state of cancer by PET: Targeting legumain with 11 C-labeled P1-Asn peptidomimetics carrying a cyano-warhead

Microfluidics for synthesis of peptide-based PET tracers.

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging.

β-Galactosidase-Activated and Red Light-Induced RNA Modification Strategy for Prolonged NIR Fluorescence/PET Bimodality Imaging

Dual Mode Fluorescent Pet Tracers: Efficient Modular Synthesis, Facile F-18-Radiolabelling, in Vivo Pet Imaging and Ex Vivo Fluorescence

Fluorine-18 incorporation and radiometal coordination in macropa ligands for PET imaging and targeted alpha therapy

Preparation and Bioevaluation of 18F-Labeled Small-Molecular Radiotracers via Sulfur(VI) Fluoride Exchange Chemistry for Imaging of Programmed Cell Death Protein Ligand 1 Expression in Tumors

Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold

Capturing aqueous 18F-fluoride with boron: One-step 18F-labeling of dimeric cycloRGD at high specific activity for functional PET imaging of tumors in mice

Tailoring a Near-Infrared Macrocyclization Scaffold Allows the Control of In Situ Self-Assembly for Photoacoustic/PET Bimodal Imaging

Synthesis, radiolabeling, and evaluation of 68Ga-labeled aminoquinoxaline derivative as a potent PFKFB3-targeted PET tracer

A versatile fluorinated azamacrocyclic chelator enabling 18 F PET or 19 F MRI : a first step towards new multimodal and smart contrast agents.

Single Step 18F-Labeling of Dimeric Cyclorgd for Functional PET Imaging of Tumors in Mice.

One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging

Dual Mode Fluorescent (18)F-PET Tracers: Efficient Modular Synthesis of Rhodamine-[Crgd]2-[(18)f]-organotrifluoroborate, Rapid, and High Yielding One-Step (18)F-Labeling at High Specific Activity, and Correlated in Vivo PET Imaging and Ex Vivo Fluorescence.